These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 27159270

  • 1. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
    Wei S, Yoshida N, Finn G, Kozono S, Nechama M, Kyttaris VC, Zhen Zhou X, Tsokos GC, Ping Lu K.
    Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
    [Abstract] [Full Text] [Related]

  • 2. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K.
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
    Lech M, Kantner C, Kulkarni OP, Ryu M, Vlasova E, Heesemann J, Anz D, Endres S, Kobayashi KS, Flavell RA, Martin J, Anders HJ.
    Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.
    Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ.
    J Am Soc Nephrol; 2007 Jun; 18(6):1721-31. PubMed ID: 17460144
    [Abstract] [Full Text] [Related]

  • 5. Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.
    Lian X, Lin YM, Kozono S, Herbert MK, Li X, Yuan X, Guo J, Guo Y, Tang M, Lin J, Huang Y, Wang B, Qiu C, Tsai CY, Xie J, Gao ZJ, Wu Y, Liu H, Zhou XZ, Lu KP, Chen Y.
    J Hematol Oncol; 2018 May 30; 11(1):73. PubMed ID: 29848341
    [Abstract] [Full Text] [Related]

  • 6. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG, Richey LJ, Bolland S, Mehta AJ, Kearney JF, Huber BT.
    Autophagy; 2015 May 30; 11(7):1010-24. PubMed ID: 26120731
    [Abstract] [Full Text] [Related]

  • 7. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L, Augusto JF, Shipley E, Contin-Bordes C, Douchet I, Mitrovic S, Truchetet ME, Lazaro E, Duffau P, Couzi L, Jacquemin C, Barnetche T, Vacher P, Schaeverbeke T, Blanco P, Richez C, Fédération Hospitalo-Universitaire ACRONIM.
    Arthritis Rheumatol; 2016 Sep 30; 68(9):2221-31. PubMed ID: 26991804
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-1 receptor associated kinase 1 is a potential therapeutic target of anti-inflammatory therapy for systemic lupus erythematosus.
    Li M, Yu D, Ni B, Hao F.
    Mol Immunol; 2017 Jul 30; 87():94-101. PubMed ID: 28431280
    [Abstract] [Full Text] [Related]

  • 9. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
    An N, Chen Y, Wang C, Yang C, Wu ZH, Xue J, Ye L, Wang S, Liu HF, Pan Q.
    Cell Physiol Biochem; 2017 Jul 30; 44(1):412-422. PubMed ID: 29141242
    [Abstract] [Full Text] [Related]

  • 10. Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE.
    Saito K, Kukita K, Kutomi G, Okuya K, Asanuma H, Tabeya T, Naishiro Y, Yamamoto M, Takahashi H, Torigoe T, Nakai A, Shinomura Y, Hirata K, Sato N, Tamura Y.
    Eur J Immunol; 2015 Jul 30; 45(7):2028-41. PubMed ID: 25871979
    [Abstract] [Full Text] [Related]

  • 11. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W, Wu-qing W, Zhu-wen Y, Zuo L.
    Lupus; 2014 Sep 30; 23(10):994-1005. PubMed ID: 24756437
    [Abstract] [Full Text] [Related]

  • 12. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
    Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW.
    Clin Exp Immunol; 2010 Jan 30; 159(1):11-22. PubMed ID: 19843090
    [Abstract] [Full Text] [Related]

  • 13. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT.
    Arthritis Rheum; 2006 Nov 30; 54(11):3601-11. PubMed ID: 17075805
    [Abstract] [Full Text] [Related]

  • 14. Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways.
    Liao XH, Zhang AL, Zheng M, Li MQ, Chen CP, Xu H, Chu QS, Yang D, Lu W, Tsai TF, Liu H, Zhou XZ, Lu KP.
    Sci Rep; 2017 Mar 06; 7():43639. PubMed ID: 28262728
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
    Liu CP, Tsai WJ, Shen CC, Lin YL, Liao JF, Chen CF, Kuo YC.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):270-9. PubMed ID: 16413531
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of microRNA-448 suppresses CD4+ T cell inflammatory activation via up-regulating suppressor of cytokine signaling 5 in systemic lupus erythematosus.
    Zhang J, Guo Y, Sun Y, Chang L, Wang X.
    Biochem Biophys Res Commun; 2022 Mar 12; 596():88-96. PubMed ID: 35121374
    [Abstract] [Full Text] [Related]

  • 17. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.
    Zhang Z, Yu W, Zheng M, Liao X, Wang J, Yang D, Lu W, Wang L, Zhang S, Liu H, Zhou XZ, Lu KP.
    Mol Carcinog; 2019 Aug 12; 58(8):1450-1464. PubMed ID: 31026381
    [Abstract] [Full Text] [Related]

  • 18. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z, Tian Z, Zhang M, Zhang Y, Ni B, Hao F.
    Immunol Invest; 2018 Jul 12; 47(5):468-483. PubMed ID: 29611775
    [Abstract] [Full Text] [Related]

  • 19. Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons.
    Stone RC, Feng D, Deng J, Singh S, Yang L, Fitzgerald-Bocarsly P, Eloranta ML, Rönnblom L, Barnes BJ.
    Arthritis Rheum; 2012 Mar 12; 64(3):788-98. PubMed ID: 21968701
    [Abstract] [Full Text] [Related]

  • 20. Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus.
    Tao B, Xiang W, Li X, He C, Chen L, Xia X, Peng T, Peng L, Yang X, Zhong C.
    Inflamm Res; 2021 Mar 12; 70(3):285-296. PubMed ID: 33507312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.